期刊文献+

肺心病合并冠心病50例临床观察 被引量:4

下载PDF
导出
摘要 选择我院2010年5月~2012年2月收治的50例肺心病与冠心病合并发症患者,观察组和对照组各25例,对照组行常规内科治疗,观察组在常规方案治疗的基础上,加用异舒吉与依拉普利治疗,回顾相关临床资料。结果观察组总有效率为92%,对照组总有效率为75%。观察组总有效率显著高于对照组(P<0.05)。两组治疗前PaCO2水平及PaO2水平无明显差异(P>0.05),治疗后观察组改善情况明显优于对照组,差异有统计学意义(P<0.05)。肺心并合并冠心病的患者在常规治疗方案应用的基础上,加用异舒吉联合依拉普利治疗,症状得到了明显改善,显著提高了临床效果,改善了患者生存质量。
作者 杨柳娟 罗波
机构地区 合山市中医院
出处 《现代诊断与治疗》 CAS 2012年第11期1923-1924,共2页 Modern Diagnosis and Treatment
  • 相关文献

参考文献8

  • 1刘群,赵冬,王薇.冠心病二级预防实施研究进展[J].心肺血管病杂志,2007,26(3):190-192. 被引量:24
  • 2Martin-Ventura J L,Blanco-Colio L M,Gomez-Hernandez A,et al.In-tensive treatment with atorvastatin reduces inflammation in mononu-clear cells and human atherosclerotic lesions in one month[J].Stroke,2005,36(8):1796-1800.
  • 3王晓平,柯会星,王厚东,侯军,缪竞智,尤广发.46例老年肺心病病理与临床对比分析[J].中华结核和呼吸杂志,1997,20(4):228-230. 被引量:41
  • 4Sturnpf C,Petzi S,Seybold K,et al.Effect of atorvastatin versus rosu-vastatin on levels of serutn lipids,inflammatory markers and adiponectin in patients with bypercholesterolemia[J].Clin Sci,2009,116:45-52.
  • 5陈勇,陈世蓉,赵超美.心电图与运动平板对冠心病的诊断价值探讨[J].西部医学,2006,18(4):395-396. 被引量:9
  • 6Carney RM,Blumenthal JA,Freedland KE,et al.Enrichd investigators.depression and late mortality after myocardial in farction in the En-hancing Recovery in Coronary Heart Disease(ENRICHD)study[J].Psychosom Med,2004,66(4):466-474.
  • 7乔珊,孙艳荪,王小花.睡眠呼吸暂停/低通气综合征患者心钠素变化及意义[J].中国呼吸与危重监护杂志,2004,3(1):43-46. 被引量:6
  • 8Nash IS,Mosca L,Blumenthal RS.Contemporary awareness and under-standing of cholesterol as a risk factor:Results of an American Hear Association National Survey[J].Source Archives of Internal Medicine,2003,163(13):1597-1600.

二级参考文献54

  • 1张敏,白春学,王言森,李善群,王少媛.阻塞性睡眠呼吸暂停综合征患者纤维蛋白原Bβ448和纤溶酶原激活物抑制物-1 4G/5G基因多态性分析[J].中国呼吸与危重监护杂志,2003,2(2):72-76. 被引量:2
  • 2钮善福.进一步拓宽面罩机械通气的临床适应证[J].中国呼吸与危重监护杂志,2002,1(4):197-198. 被引量:142
  • 3Katayanta S. Sleep apnea syndrome and hypertension. Nippon Rinsho,2000;58:571 - 578.
  • 4Maekawa M, Shiomi T. Sleep apnea syndrome and ischemic heart disease. Nippon Rinsho,2000;58: 1702- 1706.
  • 5Bonsigngnore MR, Marrone O,Insalaco G. et al. The cardiovascular effects of obstructive sleep apneas: analysis of pathogenic mechanisms. Ear Respir J, 1994 ; 7 : 786 - 805.
  • 6Tasue H,Toshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994 ; 90 : 195 - 203.
  • 7Cheung BM, Brown MJ. Plasama brain natriuretic peptide and C-type natriuretie peptide in essential hypertension. J Hyperten, 1994; 12 : 449 -454.
  • 8Klinger JR,Warburton RR, Pietras LA, et al. Genetit, disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxie mice, Am J Physiol, 1999 ; 276 : L868 - L874.
  • 9Bamdo M, Elifvated plasma brain natriuretic peptide levels in chronic respiratory fililure with eor pulmonale. Respir Dis, 1993; 147:1122.
  • 10Montserral JM, Ferrer M, Hermandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med,2001 : 164:608 - 613.

共引文献74

同被引文献12

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部